Ronald S Vladyka

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: R.p.scherer Technologies, Inc., Intermune, Inc., Fmc Corporation. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald S Vladyka. Retrieved from https://idiyas.com/inventor/ronald-s-vladyka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 5)

% Patents Active = 82.4

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 165(Granted Patents)

Location History:

Hillsborough, NJ (US) (2022)
Somerset, NJ (US) (1999 - 2023)

Company Filing History:

6 out of 126

R.p.scherer Technologies, Inc.

Biohaven Therapeutics Ltd.

patents

5. 2 out of 158

The University of Mississippi

patents

6. 1 out of 69

Ariad Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12178912 - Twin-screw dry granulation for producing solid formulations (2024-12-31),

2. 12121609 - Sublingual formulation of riluzole (2024-10-22),

3. 11660267 - Sublingual formulation of riluzole (2023-05-30),

4. 11529313 - Twin-screw dry granulation for producing solid formulations (2022-12-20),

5. 11253501 - Secnidazole formulations and use in treating bacterial vaginosis (2022-02-22),

6. 8753679 - Capsule formulation of pirfenidone and pharmaceutically acceptable excipients (2014-06-17),

7. 8496967 - Oral formulations (2013-07-30),

8. 8383150 - Granulate formulation of pirfenidone and pharmaceutically acceptable excipients (2013-02-26),

9. 7988994 - Capsule formulation of pirfenidone and pharmaceutically acceptable excipients (2011-08-02),

10. 7767225 - Capsule formulation of pirfenidone and pharmaceutically acceptable excipients (2010-08-03),

11. 6858725 - Microcrystalline cellulose cushioning granules (2005-02-22),

12. 6596312 - Hydrolyzed cellulose granulations of salts of drugs (2003-07-22),

13. 6511681 - Aqueous solubility pharmaceutical formulations (2003-01-28),

14. 6497905 - Aqueous solubility pharmaceutical formulations (2002-12-24),

15. 6379707 - Method of making granular pharmaceutical vehicle (2002-04-30),

Title: Ronald S. Vladyka: A Pioneer in Pharmaceutical Innovations

Introduction

Ronald S. Vladyka, a notable inventor based in Somerset, NJ, has made significant contributions to the field of pharmaceuticals, evidenced by his impressive portfolio of 16 patents. His innovations focus on enhancing drug formulation techniques, leading to improved therapeutic options for patients.

Latest Patents

Among his latest patents, the "Twin-screw dry granulation for producing solid formulations" stands out. This invention outlines a novel dry granulation process that employs a twin-screw extruder to granulate a powder mixture containing at least one active ingredient and one carrier. The process involves kneading the powder mixture at controlled temperatures to yield a uniformly granulated product. Additionally, the technique results in granules and tablets formulated through the twin-screw extruder process.

Another noteworthy patent is the "Sublingual formulation of riluzole". This invention describes an innovative method for sublingual administration of riluzole, aimed at treating neuropsychiatric disorders and relieving oral pain. By converting this medication into a sublingual formulation, Ronald has potentially enhanced the efficiency of treatment options available to patients.

Career Highlights

Throughout his career, Ronald has collaborated with leading companies in the pharmaceutical sector, notably R.P. Scherer Technologies, Inc. and Intermune, Inc. His work at these organizations provided a platform for him to develop and refine his groundbreaking inventions, which focus on improving patient outcomes through advanced drug formulation technologies.

Collaborations

Ronald has had the privilege of working alongside esteemed colleagues such as David F. Erkoboni and Ramachandran Radhakrishnan. Their collaborative efforts have undoubtedly contributed to the successful development and implementation of innovative pharmaceutical solutions within the industry.

Conclusion

In summary, Ronald S. Vladyka stands as a distinguished inventor whose contributions to pharmaceutical innovations have had a lasting impact on the field. His latest patents reflect a commitment to improving drug formulation and administration, paving the way for better treatment options for patients around the world. As he continues to innovate, the future of pharmaceutical technology looks promising with inventors like him at the forefront.

Profile summary based on public USPTO records.